Form 4 for MRNA Moderna
Accepted 2026-07-16 16:45:38 ET · period of report 2026-07-15 · accession 0001682852-26-000141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-16 16:45 | 2026-07-15 | MRNA | Hoge Stephen | Pres | M - OptEx | $19.15 | +53.3K | 1.54M | +4% | +$1.02M |
| DT | 2026-07-16 16:45 | 2026-07-15 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $67.60 | -53.3K | 1.48M | -3% | -$3.61M |
| DMT | 2026-07-16 16:45 | 2026-07-15 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -53.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-15 | M | A | 37,226 | $19.15 | 1,521,074 | D | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. |
| 2 | Common | Common Stock | 2026-07-15 | M | A | 16,110 | $19.15 | 1,537,184 | D | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. |
| 3 | Common | Common Stock | 2026-07-15 | S | D | 53,336 | $67.60 | 1,483,848 | D | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-07-15 | M | D | 37,226 | $0.00 | 0 | D | $19.15 · — to 2026-08-10 | 37,226 Common Stock | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. (F3) This option is fully vested and exercisable. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-07-15 | M | D | 16,110 | $0.00 | 0 | D | $19.15 · — to 2026-08-10 | 16,110 Common Stock | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. (F3) This option is fully vested and exercisable. |